Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Depression in women treated with a gonadotropin-releasing hormone agonist.

Toren P, Dor J, Mester R, Mozes T, Blumensohn R, Rehavi M, Weizman A.

Biol Psychiatry. 1996 Mar 1;39(5):378-82. No abstract available.

PMID:
8704072
2.

Psychosis associated with gonadorelin agonist administration.

Mahe V, Nartowski J, Montagnon F, Dumaine A, Glück N.

Br J Psychiatry. 1999 Sep;175:290-1. No abstract available.

PMID:
10645342
4.

Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist.

Yeshaya A, Kauschansky A, Orvieto R, Varsano I, Nussinovitch M, Ben-Rafael Z.

Acta Obstet Gynecol Scand. 1998 Mar;77(3):327-9.

PMID:
9539281
5.

Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.

Ashkenazi J, Goldman JA, Dicker D, Feldberg D, Goldman GA.

Fertil Steril. 1990 Apr;53(4):738-40. No abstract available.

PMID:
2138573
6.

Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist.

Zamberlan N, Castello R, Gatti D, Rossini M, Braga V, Fracassi E, Adami S.

Osteoporos Int. 1997;7(2):133-7.

PMID:
9166393
7.
8.

Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment.

Borderie D, Cherruau B, Dougados M, Ekindjian OG, Roux C.

Calcif Tissue Int. 1998 Jan;62(1):21-5.

PMID:
9405728
9.

No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.

Hernández ER, Gómez-Palomares JL, Ricciarelli E.

Fertil Steril. 2009 Apr;91(4 Suppl):1358-61. doi: 10.1016/j.fertnstert.2008.03.077. Epub 2008 Jun 13.

PMID:
18555236
11.

Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.

Warnock JK, Bundren JC.

Psychopharmacol Bull. 1997;33(2):311-6.

PMID:
9230649
12.

[Premature luteinization and its treatment with an LH/RH analog].

Schurz B, Egarter C, Manavi M, Huber JC.

Gynakol Rundsch. 1988;28 Suppl 2:180-2. German. No abstract available.

PMID:
2976721
13.

Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis.

Donnez J, Dewart PJ, Hedon B, Perino A, Schindler AE, Blumberg J, Querleu D.

Fertil Steril. 2004 Feb;81(2):297-304.

PMID:
14967363
14.
15.

Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.

Arrigo T, De Luca F, Antoniazzi F, Galluzzi F, Iughetti L, Pasquino AM, Salerno MC, Marseglia L, Crisafulli G.

Eur J Pediatr. 2007 Jan;166(1):73-4. Epub 2006 Aug 12. No abstract available.

PMID:
16906400
16.

[Anxiety, depression, cancer: clinical aspects].

Marx G, Gauvain-Piquard A, Saltel P.

Encephale. 1998 Dec;24 Spec No 2:66-71. Review. French. No abstract available.

PMID:
9949930
17.

Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.

De Leo V, Fulghesu AM, la Marca A, Morgante G, Pasqui L, Talluri B, Torricelli M, Caruso A.

Gynecol Endocrinol. 2000 Dec;14(6):411-6.

PMID:
11228061
18.

Four-dimensional Anxiety and Depression Scale: a preliminary psychometric report.

Bystritsky A, Waikar SV, Vapnik T.

Anxiety. 1996;2(1):47-50. No abstract available.

PMID:
9160599
19.
20.

Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety.

Comtois KA, Cowley DS, Dunner DL, Roy-Byrne PP.

J Clin Psychiatry. 1999 Nov;60(11):752-8.

PMID:
10584763
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk